UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Human papillomavirus-related oropharyngeal cancer

Annals of oncology, 2017-10, Vol.28 (10), p.2386-2398

2017

Volltextzugriff (PDF)

Epidemiology of human papillomavirus-related oropharyngeal cancer in a classically low-burden region of southern Europe

Scientific reports, 2020-08, Vol.10 (1), p.13219-13219, Article 13219

2020

Volltextzugriff (PDF)

Management of radiation dermatitis in patients receiving cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: proposals for a revised grading system and consensus management guidelines

Annals of oncology, 2011-10, Vol.22 (10), p.2191-2200

2011

Volltextzugriff (PDF)

Quality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck

Annals of oncology, 2010-10, Vol.21 (10), p.1967-1973

2010

Volltextzugriff (PDF)

Multidisciplinary management of head and neck cancer: First expert consensus using Delphi methodology from the Spanish Society for Head and Neck Cancer (part 1)

Oral oncology, 2017-07, Vol.70, p.58-64

2017

Volltextzugriff (PDF)

Epidermal growth factor receptor (EGFR) pathway polymorphisms as predictive markers of cetuximab toxicity in locally advanced head and neck squamous cell carcinoma (HNSCC) in a Spanish population

Oral oncology, 2016-12, Vol.63, p.38-43

2016

Volltextzugriff (PDF)

Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial

Annals of oncology, 2014-04, Vol.25 (4), p.801-807

2014

Volltextzugriff (PDF)

OC-021: Biomarker results from BERIL-1: buparlisib and paclitaxel in patients with platinum-pretreated SCCHN

Radiotherapy and oncology, 2017-03, Vol.122, p.14-14

2017

Volltextzugriff (PDF)

EP-1153 Nasopharyngeal carcinoma treated with intensitymodulated radiotherapy in a non-endemic area

Radiotherapy and oncology, 2015-04, Vol.115, p.S626-S627

2015

Volltextzugriff (PDF)

Influence of Treatment Received in Long-Surviving Patients of Head-and-Neck Cancer

International journal of radiation oncology, biology, physics, 2014-02, Vol.88 (2), p.531-532

2014

Volltextzugriff (PDF)

Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma

Annals of oncology, 2019-01, Vol.30 (1), p.57-67

2019

Volltextzugriff (PDF)

Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part)

Annals of oncology, 2014-03, Vol.25 (3), p.682-688

2014

Volltextzugriff (PDF)

Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study

Annals of oncology, 2020-07, Vol.31 (7), p.942-950

2020

Volltextzugriff (PDF)

Randomized placebo-controlled phase II trial of high-dose melatonin mucoadhesive oral gel for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing radiation therapy concurrent with systemic treatment

Clinical & translational oncology, 2021-09, Vol.23 (9), p.1801-1810

2021

Volltextzugriff (PDF)

PO-081: Late Toxicity After Radical Treatment for Locally Advanced Head-and-Neck Carcinomas

Radiotherapy and oncology, 2013-02, Vol.106, p.S34-S35

2013

Volltextzugriff (PDF)

EP-1221 RESULTS OF CONCURRENT HYPERFRACTIONATED CHEMO-RADIOTHERAPY IN LIMITED SMALL-CELL LUNG CANCER (LD-SCLC)

Radiotherapy and oncology, 2012-05, Vol.103, p.S469-S469

2012

Volltextzugriff (PDF)

Adjuvant therapy with cetuximab for locally advanced squamous cell carcinoma of the oropharynx: results from a randomized, phase II prospective trial

Annals of oncology, 2013-02, Vol.24 (2), p.448-453

2013

Volltextzugriff (PDF)

Multidisciplinary management of head and neck cancer: First expert consensus using Delphi methodology from the Spanish Society for Head and Neck Cancer (part 2)

Oral oncology, 2017-07, Vol.70, p.65-72

2017

Volltextzugriff (PDF)

KEYNOTE-048: Phase III study of first-line pembrolizumab (P) for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC)

Annals of oncology, 2018-10, Vol.29, p.viii729-viii729

2018

Volltextzugriff (PDF)

Sequential chemotherapy regimen of induction with panitumumab and paclitaxel followed by radiotherapy and panitumumab in patients with locally advanced head and neck cancer unfit for platinum derivatives. The phase II, PANTERA/TTCC-2010-06 study

Clinical & translational oncology, 2021-08, Vol.23 (8), p.1666-1677

2021

Volltextzugriff (PDF)

SEOM clinical guidelines for the treatment of head and neck cancer (2020)

Clinical & translational oncology, 2021-05, Vol.23 (5), p.913-921

2021

Volltextzugriff (PDF)

Nutritional changes in patients with locally advanced head and neck cancer during treatment

Oral oncology, 2017-08, Vol.71, p.67-74

2017

Volltextzugriff (PDF)

Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck

Annals of oncology, 2008-01, Vol.19 (1), p.142-149

2008

Volltextzugriff (PDF)

Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study

Annals of oncology, 2011-05, Vol.22 (5), p.1078-1087

2011

Volltextzugriff (PDF)

1596P SERONCOVID: Seroconversion in solid-tumor cancer patients (p) after COVID-19 diagnosis

Annals of oncology, 2021-09, Vol.32, p.S1145-S1145

2021

Volltextzugriff (PDF)

1 – 25 von 311

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(299)
Mit Volltextzugriff
(289)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(118)
Life Sciences & Biomedicine
(109)
Humans
(86)
Female
(65)
Biological And Medical Sciences
(55)
Oncology
(51)
Male
(48)
Medical Sciences
(46)
Middle Aged
(44)
Adult
(42)
Aged
(33)
Tumors
(24)
Animals
(22)
Pharmacology. Drug Treatments
(22)
Hematology, Oncology And Palliative Medicine
(20)
Pharmacology & Pharmacy
(20)
Medicine
(16)
Plant Sciences
(16)
Cetuximab
(15)
Medicine & Public Health
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Human papillomavirus-related oropharyngeal cancer

Epidemiology of human papillomavirus-related oropharyngeal cancer in a classically low-burden region of southern Europe

Management of radiation dermatitis in patients receiving cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: proposals for a revised grading system and consensus management guidelines

Quality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck

Multidisciplinary management of head and neck cancer: First expert consensus using Delphi methodology from the Spanish Society for Head and Neck Cancer (part 1)

Epidermal growth factor receptor (EGFR) pathway polymorphisms as predictive markers of cetuximab toxicity in locally advanced head and neck squamous cell carcinoma (HNSCC) in a Spanish population

Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial

OC-021: Biomarker results from BERIL-1: buparlisib and paclitaxel in patients with platinum-pretreated SCCHN

EP-1153 Nasopharyngeal carcinoma treated with intensitymodulated radiotherapy in a non-endemic area

Influence of Treatment Received in Long-Surviving Patients of Head-and-Neck Cancer

Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma

Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part)

Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study

Randomized placebo-controlled phase II trial of high-dose melatonin mucoadhesive oral gel for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing radiation therapy concurrent with systemic treatment

PO-081: Late Toxicity After Radical Treatment for Locally Advanced Head-and-Neck Carcinomas

EP-1221 RESULTS OF CONCURRENT HYPERFRACTIONATED CHEMO-RADIOTHERAPY IN LIMITED SMALL-CELL LUNG CANCER (LD-SCLC)

Adjuvant therapy with cetuximab for locally advanced squamous cell carcinoma of the oropharynx: results from a randomized, phase II prospective trial

Multidisciplinary management of head and neck cancer: First expert consensus using Delphi methodology from the Spanish Society for Head and Neck Cancer (part 2)

KEYNOTE-048: Phase III study of first-line pembrolizumab (P) for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC)

Sequential chemotherapy regimen of induction with panitumumab and paclitaxel followed by radiotherapy and panitumumab in patients with locally advanced head and neck cancer unfit for platinum derivatives. The phase II, PANTERA/TTCC-2010-06 study

SEOM clinical guidelines for the treatment of head and neck cancer (2020)

Nutritional changes in patients with locally advanced head and neck cancer during treatment

Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck

Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study

1596P SERONCOVID: Seroconversion in solid-tumor cancer patients (p) after COVID-19 diagnosis

Suchergebnisse filtern